24 Jun 2026 JAMA Surgery Publishes Landmark BrIMA Study Demonstrating Significant Improvement in Intraoperative Margin Assessment with Specimen PET-CT Multiple categories
01 Jun 2026 Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia Multiple categories
12 May 2026 Flen Health Pharma NV Receives Positive FDA Feedback on VES Gel for Diabetic Foot Ulcers Multiple categories
30 Apr 2026 Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554 Multiple categories
02 Apr 2026 SwiftPharma Expands R&D Footprint to Leuven in Strategic Co-Location with Benno Therapeutics Multiple categories
19 Feb 2026 SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
25 Aug 2025 argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Multiple categories
23 Jul 2025 KU Leuven researchers identify promising drug for treating severe malaria Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
